Nachrichten zur Johnson Matthey PLC Aktie

Johnson & Johnson (JNJ) Exceeds Market Returns: Some Facts to Consider

The latest trading day saw Johnson & Johnson (JNJ) settling at $155.36, representing a +1.38% change from its previous close.…

NMAX, WTF, JNJ, HIMS, TSLA: Top 5 Trending Stocks Today - Hims & Hers Health (NYSE:HIMS), Johnson & Johnson (NYSE:JNJ)

U.S. stocks closed higher on Tuesday, with the Nasdaq Composite climbing 0.9% to 17,449.89. The S&P 500 added nearly 0.4%,…

Hims & Hers adds Eli Lilly GLP-1 drugs, Johnson & Johnson setback

Yahoo Finance Senior Reporter Anjalee Khemlani joins Market Domination to discuss some of the top stories of the trading day,…

Johnson & Johnson Aktie: Babypuder-Prozess belastet - Kurs bricht ein

Kulmbach (www.aktiencheck.de) - Johnson & Johnson-Aktienanalyse von "Der Aktionär": Markus Bußler vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Johnson &…

Warten auf das Zollpaket: Dow kaum verändert - Johnson & Johnson unter Druck

Einen Tag vor der Verkündung einschneidender Importzölle in den USA haben sich Investoren an der Wall Street merklich zurückgehalten. Der…

Warten auf das Zollpaket: Dow kaum verändert – Johnson & Johnson unter Druck

Einen Tag vor der Verkündung einschneidender Importzölle in den USA haben sich Investoren an der Wall Street merklich zurückgehalten. Der…

Warten auf das Zollpaket: Dow kaum verändert – Johnson & Johnson unter Druck

Einen Tag vor der Verkündung einschneidender Importzölle in den USA haben sich Investoren an der Wall Street merklich zurückgehalten. Der…

Can Johnson & Johnson (JNJ) Keep the Earnings Surprise Streak Alive?

Johnson & Johnson (JNJ) has an impressive earnings surprise history and currently possesses the right combination of the two key…

ROUNDUP/Erneut juristischer Dämpfer für J&J: Keine Lösung für Babypuder-Klagen

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) muss im Streit um angebliche Gesundheitsrisiken bestimmter Babypuder vor…

ROUNDUP/Erneut juristischer Dämpfer für J&J: Keine Lösung für Babypuder-Klagen

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (JohnsonJohnson) (J&J) muss im Streit um angebliche Gesundheitsrisiken bestimmter Babypuder vor…

dpa-AFX-Überblick: UNTERNEHMEN vom 01.04.2025 - 15.15 Uhr

Juristische Watsche für J&J: Treuhandfonds für Babypuder-Klagen erneut abgelehnt NEW BRUNSWICK - Der US-Konzern Johnson & Johnson…

Juristische Watsche für J&J: Treuhandfonds für Babypuder-Klagen erneut abgelehnt

NEW BRUNSWICK (dpa-AFX) - Der US-Konzern Johnson & Johnson (J&J) hat im Streit um angebliche Gesundheitsrisiken bestimmter Babypuder…

Stocks making the biggest moves premarket: PVH, Johnson & Johnson, Newsmax, Shake Shack and more

These are the stocks posting the largest moves in premarket trading.…

Johnson & Johnson shares fall as US judge rejects $10B talc settlement plan

Johnson & Johnson (NYSE:JNJ) shares moved almost 5% lower after a US bankruptcy judge rejected its $10 billion settlement proposal…

J&J shares fall after judge rejects $10 billion talc settlement

Johnson & Johnson shares fell more than 3% on Tuesday after a U.S. bankruptcy judge rejected its $10 billion proposal…

Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Procter & Gamble, Johnson & Johnson Among 10 Companies To Announce Dividend Increases In First Half Of April

…

3 Relatively Safe Stocks to Buy Right Now

Investing in stocks comes with risks. Theres no way around that fact. However, some stocks can be less risky than…

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case By Reuters

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case…

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case

A federal judge ordered Janssen to pay $1.64 billion after a jury found it liable in a whistleblower lawsuit for…

Deutsche Bank belässt Astrazeneca auf Hold - Ziel 11000 Pence

FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Astrazeneca auf "Hold" mit einem Kursziel von 11000 Pence…

Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts

The latest trading day saw Johnson & Johnson (JNJ) settling at $163.29, representing a -0.21% change from its previous close.…

Johnson & Johnson to invest more than $55bn in US over next four years

The commitment marks a 25% increase to the companys US investments in the past four years…

List of companies pledging to invest billions in US since Donald Trump win

Trump has brought in some big investments in his two months in office, most recently Johnson & Johnson.…

J&J touts $55B in planned US investments over 4 years, including 3 new manufacturing sites

Johnson & Johnson says it will s | Johnson & Johnson will invest $55 billion in the U.S. over the…

J&J boosts investments in U.S. to more than $55 billion amid looming tariff threats

Johnson & Johnson plans to spend over $55 billion to build four plants in the U.S., it said on Friday.…

J&J boosts investments in US to more than $55 billion amid looming tariff threats

Johnson & Johnson plans to spend over $55 billion to build four plants in the U.S., it said on Friday.…

Johnson & Johnson plans $55 billion in US investments over the next four years

Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years,…

Johnson & Johnson plans $55 billion in US investments over the next four years

Johnson & Johnson says it will invest more than $55 billion within the United States over the next four years,…

Pharma: Johnson & Johnson will über 55 Milliarden Dollar in USA investieren

Der Pharmakonzern will seine Investitionen in den USA ausweiten. Es sollen zusätzliche Produktionsstätten und Forschungsinfrastruktur entstehen.…

J&J plans to invest more than $55 billion in US over next four years

Johnson & Johnson said on Friday it plans to invest more than $55 billion over the next four years to…

Top Stock Reports for Visa, Johnson & Johnson & Thermo Fisher Scientific

Todays Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Johnson & Johnson (JNJ) and…

Johnson & Johnson (JNJ) Rises But Trails Market: What Investors Should Know

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $162.84, denoting a +0.02% change from…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts…

Johnson & Johnson zieht die Reißleine - Genmab-Aktie bricht ein

Die Zusammenarbeit zwischen dem US-Pharmazie- und Konsumgüterhersteller Johnson & Johnson und dem dänischen Onkologie-Spezialisten Genmab ist vor allem bei der…

Zacks Investment Ideas feature highlights: Coca-Cola, Philip Morris and Johnson & Johnson

Coca-Cola, Philip Morris and Johnson & Johnson are part of the Zacks Investment Ideas article.…

Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson

Gilead Sciences and Johnson & Johnson are part of the Zacks Investment Ideas article.…

3 ETFs to Buy Now for Passive Dividend Income

With volatility spiking and stock market indexes like the S&P 500 (SNPINDEX: ^GSPC) and Nasdaq Composite (NASDAQINDEX: ^IXIC) down on…

Pfizer Vs. Johnson & Johnson: Whos The Better Bargain For Investors

…

Kenvue settles proxy fight with activist Starboard, adding three directors to its board

Starboards Jeff Smith will join the board of the Johnson & Johnson spinoff.…

Buy Johnson & Johnson (JNJ) Stock for Higher Highs?

Amid recent market volatility, Johnson & Johnson (JNJ) stock hit new 52-week highs of nearly $170 on Tuesday.…

Why the Market Dipped But Johnson & Johnson (JNJ) Gained Today

Johnson & Johnson (JNJ) reachead $167.28 at the closing of the latest trading day, reflecting a +1.37% change compared to…

3 Dividend Stocks That Are No-Brainer Buys Right Now

It can be difficult to decide which dividend stocks to buy. After all, more than 5,700 of them trade on…

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy…

Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note

In the closing of the recent trading day, Johnson & Johnson (JNJ) stood at $166.09, denoting a +1.44% change from…

J&J sues Samsung Bioepis over contract breach for Stelara biosimilar

Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with…

Healthcare sector leads S&P 500 YTD, Johnson & Johnson and Gilead show promise

Healthcare sector leads S&P 500 YTD, Johnson & Johnson and Gilead show promise - BTIG…

Johnson & Johnson (JNJ) Up 8.9% Since Last Earnings Report: Can It Continue?

Johnson & Johnson (JNJ) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…

Johnson Johnson: Die Marken des Unternehmens

Johnson Johnson steht - ähnlich wie auch andere Grosskonzerne - hinter vielen Marken, von denen Kunden oft gar nicht…